GOVERNMENT COUNSEL, LLC for APOTEX CORPORATION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S. 1895-Lower Health Care Costs Act (Section 205); issues relating to pharmaceutical market blockages caused by parked Hatch-Waxman 180-day exclusivity periods.
Foreign entity interest: Aposherm Inc. and Apotex Holdings Inc., parent companies of Apotex Corp. identified on the LD-1, have direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs and therefore are interested in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.